Crossmark

Silymarin inhibits the progression of Ehrlich solid tumor via targeting molecular pathways of cell death, proliferation, angiogenesis, and metastasis in female mice

Crossref DOI link: https://doi.org/10.1007/s11033-022-07315-2

Published Online: 2022-03-19

Published Print: 2022-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Amer, Maggie E. https://orcid.org/0000-0003-2012-9154
Amer, Maher A.

Othman, Azza I. https://orcid.org/0000-0001-8624-1259
Elsayed, Doaa A. https://orcid.org/0000-0002-9000-6646
El-Missiry, Mohamed Amr https://orcid.org/0000-0002-4566-0497
Ammar, Omar A. https://orcid.org/0000-0001-9377-6462
License Information

Text and Data Mining valid from 2022-03-19

Version of Record valid from 2022-03-19
More Information

Article History

Received: 30 December 2021

Accepted: 1 March 2022

First Online: 19 March 2022

Declarations

:

: The authors declare that they have no conflict of interest.

: All procedures performed in this study were conducted in accordance with the regulations approved by the Ethics Committee at Faculty of Science, Mansoura University, Egypt.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below